In a rapidly evolving pharmaceutical landscape, the integration of artificial intelligence (AI) into drug development processes has emerged as a game-changer. Major players in the pharmaceutical industry, including Amgen, Bayer, and Novartis, are increasingly harnessing the power of AI to expedite clinical trials, reduce costs, and ultimately bring life-saving medications to market more swiftly. This ... Read more
